Table 2.
Comparison of DNA methylation levels between groups
Patients | Controls | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CpG sites | Max | Min | M | SD | Max | Min | M | SD | B | SE | z value | P | OR | OR(95%CI) |
CpG_1/3/8 | 0.38 | 0.00 | 0.21 | 0.09 | 0.55 | 0.00 | 0.21 | 0.09 | −0.495 | 2.245 | 0.049 | 0.825 | 0.610 | 0.007 ~ 49.624 |
CpG_2 | 0.64 | 0.28 | 0.45 | 0.09 | 0.64 | 0.00 | 0.47 | 0.10 | −2.249 | 2.036 | 1.220 | 0.269 | 0.106 | 0.002 ~ 5.704 |
CpG_4 | 1.00 | 0.07 | 0.76 | 0.25 | 1.00 | 0.22 | 0.81 | 0.21 | −0.753 | 0.845 | 0.794 | 0.373 | 0.471 | 0.090 ~ 2.468 |
CpG_5 | 0.42 | 0.00 | 0.09 | 0.07 | 0.25 | 0.00 | 0.11 | 0.06 | −2.876 | 2.949 | 0.951 | 0.329 | 0.056 | 0.000 ~ 18.235 |
CpG_6 | 0.47 | 0.00 | 0.22 | 0.13 | 0.35 | 0.00 | 0.14 | 0.08 | 7.565 | 1.931 | 15.351 | < 0.001** | 1928.580 | 43.833 ~ 84,853.465 |
CpG_7 | 0.31 | 0.00 | 0.08 | 0.06 | 0.47 | 0.00 | 0.08 | 0.08 | −2.868 | 2.845 | 1.017 | 0.313 | 0.057 | 0.000 ~ 14.987 |
CpG_9 | 0.21 | 0.00 | 0.05 | 0.05 | 0.18 | 0.00 | 0.05 | 0.04 | −1.297 | 4.773 | 0.074 | 0.786 | 0.273 | 0.000 ~ 3161.378 |
CpG_10 | 0.20 | 0.00 | 0.08 | 0.04 | 0.37 | 0.00 | 0.08 | 0.05 | −2.694 | 4.045 | 0.444 | 0.505 | 0.068 | 0.000 ~ 187.491 |
CpG_11 | 0.33 | 0.00 | 0.07 | 0.07 | 0.89 | 0.00 | 0.07 | 0.11 | −0.216 | 1.948 | 0.012 | 0.912 | 0.806 | 0.018 ~ 36.662 |
CpG_12 | 0.92 | 0.00 | 0.10 | 0.15 | 0.56 | 0.00 | 0.09 | 0.11 | 0.485 | 1.465 | 0.110 | 0.740 | 1.625 | 0.092 ~ 28.678 |
CpG Cytosine-phosphate-Guanine, Max maximum, Min minimum, M mean, SD standard deviation, B regression coefficient, SE Standard Error, z value, Wald Z-Score, OR Odds Ratio, OR (95% CI), Odds Ratio with 95% Confidence Interval
P, P-value; *P < 0.05, **P < 0.01